Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sohini Mondal

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Valued at a market cap of $228.3 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, manufactures, and sells healthcare products. The company operates in four segments: Established Pharmaceutical Products; Diagnostic Products; Nutritional Products; and Medical Devices. Based in North Chicago, Illinois, ABT is expected to unveil its fiscal Q1 2025 earnings results before the market opens on Wednesday, Apr. 16.

Ahead of this event, analysts expect the company to report a profit of $1.07 per share, up 9.2% from $0.98 per share in the year-ago quarter. The company has surpassed or met Wall Street's earnings estimates in the last four quarters. In Q4 2024, ABT met the consensus EPS estimate.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.